155 related articles for article (PubMed ID: 22664073)
1. Bacterial cell wall compounds as promising targets of antimicrobial agents II. Immunological and clinical aspects.
Schuerholz T; Dömming S; Hornef M; Dupont A; Kowalski I; Kaconis Y; Heinbockel L; Andrä J; Garidel P; Gutsmann T; David S; Sánchez-Gómez S; Martinez de Tejada G; Brandenburg K
Curr Drug Targets; 2012 Aug; 13(9):1131-7. PubMed ID: 22664073
[TBL] [Abstract][Full Text] [Related]
2. Bacterial cell wall compounds as promising targets of antimicrobial agents I. Antimicrobial peptides and lipopolyamines.
Martínez de Tejada G; Sánchez-Gómez S; Rázquin-Olazaran I; Kowalski I; Kaconis Y; Heinbockel L; Andrä J; Schürholz T; Hornef M; Dupont A; Garidel P; Lohner K; Gutsmann T; David SA; Brandenburg K
Curr Drug Targets; 2012 Aug; 13(9):1121-30. PubMed ID: 22664072
[TBL] [Abstract][Full Text] [Related]
3. Gram-positive bacterial cell envelopes: The impact on the activity of antimicrobial peptides.
Malanovic N; Lohner K
Biochim Biophys Acta; 2016 May; 1858(5):936-46. PubMed ID: 26577273
[TBL] [Abstract][Full Text] [Related]
4. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
Münch D; Sahl HG
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial agents targeting bacterial cell walls and cell membranes.
Bush K
Rev Sci Tech; 2012 Apr; 31(1):43-56. PubMed ID: 22849267
[TBL] [Abstract][Full Text] [Related]
6. NMR Structures and Interactions of Antimicrobial Peptides with Lipopolysaccharide: Connecting Structures to Functions.
Bhattacharjya S
Curr Top Med Chem; 2016; 16(1):4-15. PubMed ID: 26139110
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Targeting Mechanisms by Antimicrobial Peptides.
Le CF; Fang CM; Sekaran SD
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167546
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity profiles of Amphiphilic Xanthone derivatives are a function of their molecular Oligomerization.
Koh JJ; Lin S; Bai Y; Sin WWL; Aung TT; Li J; Chandra V; Pervushin K; Beuerman RW; Liu S
Biochim Biophys Acta Biomembr; 2018 Nov; 1860(11):2281-2298. PubMed ID: 29782818
[TBL] [Abstract][Full Text] [Related]
9. Interaction between antimicrobial peptides and mycobacteria.
Gutsmann T
Biochim Biophys Acta; 2016 May; 1858(5):1034-43. PubMed ID: 26851776
[TBL] [Abstract][Full Text] [Related]
10. Overview of ribosomal and non-ribosomal antimicrobial peptides produced by Gram positive bacteria.
Tajbakhsh M; Karimi A; Fallah F; Akhavan MM
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):20-32. PubMed ID: 29096754
[TBL] [Abstract][Full Text] [Related]
11. Outer membrane permeabilization by the membrane attack complex sensitizes Gram-negative bacteria to antimicrobial proteins in serum and phagocytes.
Heesterbeek DAC; Muts RM; van Hensbergen VP; de Saint Aulaire P; Wennekes T; Bardoel BW; van Sorge NM; Rooijakkers SHM
PLoS Pathog; 2021 Jan; 17(1):e1009227. PubMed ID: 33481964
[TBL] [Abstract][Full Text] [Related]
12. Ceragenins (cationic steroid compounds), a novel class of antimicrobial agents.
Epand RM; Epand RF; Savage PB
Drug News Perspect; 2008; 21(6):307-11. PubMed ID: 18836587
[TBL] [Abstract][Full Text] [Related]
13. Cn-AMP1: a new promiscuous peptide with potential for microbial infections treatment.
Silva ON; Porto WF; Migliolo L; Mandal SM; Gomes DG; Holanda HH; Silva RS; Dias SC; Costa MP; Costa CR; Silva MR; Rezende TM; Franco OL
Biopolymers; 2012; 98(4):322-31. PubMed ID: 23193596
[TBL] [Abstract][Full Text] [Related]
14. Membrane-active Antimicrobial Peptides as Template Structures for Novel Antibiotic Agents.
Lohner K
Curr Top Med Chem; 2017; 17(5):508-519. PubMed ID: 28117020
[TBL] [Abstract][Full Text] [Related]
15. Temporins and their synergism against Gram-negative bacteria and in lipopolysaccharide detoxification.
Mangoni ML; Shai Y
Biochim Biophys Acta; 2009 Aug; 1788(8):1610-9. PubMed ID: 19422786
[TBL] [Abstract][Full Text] [Related]
16. Marine Antimicrobial Peptides: Nature Provides Templates for the Design of Novel Compounds against Pathogenic Bacteria.
Falanga A; Lombardi L; Franci G; Vitiello M; Iovene MR; Morelli G; Galdiero M; Galdiero S
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213366
[TBL] [Abstract][Full Text] [Related]
17. MD-2 enables Toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to Gram-positive and Gram-negative bacteria and their cell wall components.
Dziarski R; Wang Q; Miyake K; Kirschning CJ; Gupta D
J Immunol; 2001 Feb; 166(3):1938-44. PubMed ID: 11160242
[TBL] [Abstract][Full Text] [Related]
18. Derivatives of Ribosome-Inhibiting Antibiotic Chloramphenicol Inhibit the Biosynthesis of Bacterial Cell Wall.
Louzoun Zada S; Green KD; Shrestha SK; Herzog IM; Garneau-Tsodikova S; Fridman M
ACS Infect Dis; 2018 Jul; 4(7):1121-1129. PubMed ID: 29714997
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria.
Chung PY; Khanum R
J Microbiol Immunol Infect; 2017 Aug; 50(4):405-410. PubMed ID: 28690026
[TBL] [Abstract][Full Text] [Related]
20. D-form KLKLLLLLKLK-NH
Manabe T; Kawasaki K
Sci Rep; 2017 Mar; 7():43384. PubMed ID: 28262682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
